⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
businesswire.com
AZN
Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
globenewswire.com
AZN
Inaugural 'Here Comes Summer' Benefit Fuels Lung Cancer Research, Honors Legacy of Donna Summer
prnewswire.com
AZN
BioInvent's BI-1206 Triplet Achieves 83% Response Rate in Refractory NHL with Improved Safety vs. SOC (EHA 2026)
accessnewswire.com
AZN
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
globenewswire.com
NVS
TLX
PFE
EXEL
LLY
XNCR
BTE
ORIC
MRK
ABBV
BMY
AZN
AMGN
Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight
globenewswire.com
AZN
NVS
ABBV
BMY
GILD
REGN
VRTX
BIIB
JNJ
MRK
ARWR
TAK
VERA
Retool Achieves AWS Consumer Goods Competency
businesswire.com
AMZN
COIN
DDOG
ADBE
NFLX
AAPL
GOOG
CHTR
NVDA
MSFT
INTC
AMD
TSLA
META
CRM
IBM
ORCL
CSCO
ACN
PYPL
UPST
PLTR
SNOW
CRWD
PANW
ZS
MDB
AFRM
SOFI
UPWK
FIVN
DOCU
SMCI
ASML
AMAT
KLAC
LRCX
MU
WDC
NXPI
QCOM
MRVL
ADSK
CDNS
SNPS
AMGN
GILD
BMY
LLY
REGN
VRTX
BIIB
AZN
XOM
CVX
SHEL
T
VZ
TMUS
CMCSA
DIS
GOOGL
Questex’s Fierce Life Sciences Announces the 2026 Partnerships with Sites Summit Agenda
globenewswire.com
LLY
BIIB
AZN
BMY
MRK
TEVA
NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
prnewswire.com
SSMR
AZN
FTRA
ICE
Form 8-K
sec.gov
TPST
VRTX
AMGN
AZN
BMY
FLEX